Hubei Goto Biopharm Co.,Ltd. (SHE:300966)

Hubei Goto Biopharm Statistics

Total Valuation

SHE:300966 has a market cap or net worth of CNY 2.25 billion. The enterprise value is 3.42 billion.

Market Cap	2.25B
Enterprise Value	3.42B

Important Dates

The next estimated earnings date is Friday, August 29, 2025.

Earnings Date	Aug 29, 2025
Ex-Dividend Date	n/a

Share Statistics

SHE:300966 has 115.28 million shares outstanding. The number of shares has increased by 1.27% in one year.

Current Share Class	115.28M
Shares Outstanding	115.28M
Shares Change (YoY)	+1.27%
Shares Change (QoQ)	+2.28%
Owned by Insiders (%)	44.66%
Owned by Institutions (%)	3.32%
Float	54.20M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	4.06
PB Ratio	2.22
P/TBV Ratio	2.58
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 102.04, with an EV/FCF ratio of -9.48.

EV / Earnings	-113.80
EV / Sales	6.18
EV / EBITDA	102.04
EV / EBIT	n/a
EV / FCF	-9.48

Financial Position

The company has a current ratio of 1.05, with a Debt / Equity ratio of 1.23.

Current Ratio	1.05
Quick Ratio	0.49
Debt / Equity	1.23
Debt / EBITDA	36.99
Debt / FCF	-3.44
Interest Coverage	-0.45

Financial Efficiency

Return on equity (ROE) is -3.46% and return on invested capital (ROIC) is -0.42%.

Return on Equity (ROE)	-3.46%
Return on Assets (ROA)	-0.32%
Return on Invested Capital (ROIC)	-0.42%
Return on Capital Employed (ROCE)	-0.66%
Revenue Per Employee	677,581
Profits Per Employee	-36,789
Employee Count	817
Asset Turnover	0.21
Inventory Turnover	1.11

Taxes

Income Tax	-16.54M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +22.15% in the last 52 weeks. The beta is 0.20, so SHE:300966's price volatility has been lower than the market average.

Beta (5Y)	0.20
52-Week Price Change	+22.15%
50-Day Moving Average	17.93
200-Day Moving Average	17.26
Relative Strength Index (RSI)	67.15
Average Volume (20 Days)	2,411,315

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SHE:300966 had revenue of CNY 553.58 million and -30.06 million in losses. Loss per share was -0.27.

Revenue	553.58M
Gross Profit	108.28M
Operating Income	-13.85M
Pretax Income	-51.85M
Net Income	-30.06M
EBITDA	33.26M
EBIT	-13.85M
Loss Per Share	-0.27

Balance Sheet

The company has 157.14 million in cash and 1.24 billion in debt, giving a net cash position of -1.08 billion or -9.39 per share.

Cash & Cash Equivalents	157.14M
Total Debt	1.24B
Net Cash	-1.08B
Net Cash Per Share	-9.39
Equity (Book Value)	1.01B
Book Value Per Share	8.00
Working Capital	45.10M

Cash Flow

In the last 12 months, operating cash flow was -25.14 million and capital expenditures -335.64 million, giving a free cash flow of -360.78 million.

Operating Cash Flow	-25.14M
Capital Expenditures	-335.64M
Free Cash Flow	-360.78M
FCF Per Share	-3.13

Margins

Gross margin is 19.56%, with operating and profit margins of -2.50% and -5.43%.

Gross Margin	19.56%
Operating Margin	-2.50%
Pretax Margin	-9.37%
Profit Margin	-5.43%
EBITDA Margin	6.01%
EBIT Margin	-2.50%
FCF Margin	n/a

Dividends & Yields

SHE:300966 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.27%
Shareholder Yield	n/a
Earnings Yield	-1.34%
FCF Yield	-16.05%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

SHE:300966 has an Altman Z-Score of 0.96 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.96
Piotroski F-Score	1